Moleculin Biotech Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Net Income	-29.77	-29.03	-15.89	-17.36	-13.21	-11.88	-9.81	-3.93	-0.37	-1.81
Depreciation & Amortization	0.13	0.13	0.16	0.2	0.2	0.07	0.02	0.01	0.01	0.01
Share-Based Compensation	1.98	2.28	2.37	1.68	1.54	1.14	0.71	0.32	0	0
Other Operating Activities	3.56	-1.02	-5.59	-2.3	-5.73	-1.54	1.76	-0.17	-0.37	0.44
Operating Cash Flow	-24.1	-27.64	-18.95	-17.77	-17.2	-12.2	-7.32	-3.77	-0.72	-1.35
Capital Expenditures	-0.12	-0.07	-0.02	-0.37	-0.05	-0.42	-0.03	-0.02	0	0
Acquisitions	0	0	0	0	0	0	0	-0.1	0	0
Change in Investments	0	0	0	0	0	0	0	0	0.23	0
Investing Cash Flow	-0.12	-0.07	-0.02	-0.37	-0.05	-0.42	-0.03	-0.12	0.23	0
Share Issuance / Repurchase	4.17	0	74.75	22.57	20.85	12.05	10.06	9.17	0	0
Debt Issued / Paid	0	0	0	0	0	0	0	-0.31	0	1.53
Other Financing Activities	0.49	-0.02	-0.02	-0.02	-	-	-	-	-	-
Financing Cash Flow	4.65	-0.02	74.72	22.55	20.85	12.05	10.06	8.87	0	1.53
Exchange Rate Effect	-0.02	-0.03	-0.02	0.03	-0	-0.01	0	0	0	0
Net Cash Flow	-19.6	-27.76	55.73	4.44	3.6	-0.58	2.71	4.98	-0.49	0.17
Free Cash Flow	-24.23	-27.71	-18.97	-18.15	-17.25	-12.62	-7.35	-3.79	-0.72	-1.35
Free Cash Flow Per Share	-12.26	-14.53	-10.59	-27.64	-38.12	-43.85	-35.63	-34.67	-9.88	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).